Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

Wedelolactone may help treat lung fibrosis by reducing inflammation and lung damage.

The 595-nm pulsed dye laser effectively reduces symptoms of EFFC with minimal side effects.

Intravenous delivery of autologous activated platelet-rich plasma is safe.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Platelet-rich plasma speeds up bone healing and reduces complications.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Platelet-rich plasma (PRP) effectively improves acne scars.

Pranlukast and mirabegron may work as new diabetes drugs.

Blocking certain immune signals can reduce skin damage from radiation therapy.

The hydrogel with fractionated PRP improves skin regeneration by enhancing wound healing and growth of skin structures.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

The EG7 foam dressing improved wound healing and reduced inflammation better than other treatments.

Platelet-rich plasma (PRP) treatments are not effective.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.